The Global AMR R&D Hub Newsletter March 2021 on ‘Incentives – Updates & New Insights’ is available. You can access the newsletter here.
Don’t miss out our latest news and subscribe to our newsletter on Global AMR R&D Hub – Global AMR R&D Hub (globalamrhub.org)
What tools do National health systems have at their disposal to further reward the development and uptake of much needed new antibiotics and diagnostics? Undertaken by the team at the Austrian Institute of Public Health (GÖG), the Global AMR R&D Hub is happy to publicly-release this important study today. This comprehensive review of available policy tools within pricing, reimbursement and procurement in ten G20 countries, includes concrete examples and suggestions for learning, leverage and implementation. This is one of three studies that were used to derive our recently-published recommendations put forward to the G7 and G20 for their ongoing reflections. Download the full report here and the accompanying policy brief here.
10.02.2021: The Hub is excited to announce a new collaboration with PAR Foundation, who will use the Dynamic Dashboard to help inform priorities for grant-making. We look forward to a successful partnership! Read the article here
28.01.2021: The Dynamic Dashboard now also shows data on projects financed by public and philanthropic funders that support human health-related AMR R&D addressing fungi. A short report with an initial analysis of the first set of more than 1000 such projects is available here.
28.01.2021: The Global AMR R&D Hub is pleased to announce the launch of the Funding Distributor Report in the Investment Gallery on the Dynamic Dashboard today. It shows funds going into and amount of funding going to activities supported by GARDP and CARB-X. You can access the report here https://dashboard.globalamrhub.org/reports/investments/funding-distributors
20.12.2020: The Global AMR R&D Hub would like to thank all participants that either attended or presented at our virtual conference held on 2 December 2020. The recordings of all three conference sessions are now available as is the conference report that highlights the recommendations arising from the discussions. Please click here
15.12.2020: In collaboration with the EU Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI), the Global AMR R&D Hub publishes a policy brief “Incentivizing antibiotic access and innovation”. The brief presents the overall results from in-depth interviews with 13 countries – including 3 x outside of the EU. Findings include general support for antibiotic incentives, with the majority of interviewed countries preferring incentives that will secure access to both old and new antibiotics. Countries want more information on suitable multinational models and costs. Full manuscript is expected in 2021. Read the policy brief here.
19.11.2020: As of today the Dynamic Dashboard shows data on the close to 1900 organisations from 64 countries across the world that receive funding for AMR R&D. This new expansion of the functionalities allows a detailed look at the global fabric of AMR R&D. Several existing reports in the Dynamic Dashboard now allow filtering by the type of research organisation. Access the report at: https://dashboard.globalamrhub.org/reports/investments/research-organisations
18.11.2020: The Global AMR R&D Hub publishes its first report “The state of public and philanthropic investments in AMR R&D – The 2020 annual report of the Global AMR R&D Hub’s Dynamic Dashboard”. Based on the report the Board of Members has issued recommendations to the Group of 20.
The report represents the first consolidation of national AMR-related R&D funding and a start to providing a comprehensive global picture.
We are happy to invite you to our virtual conference “Translating AMR R&D mapping into policy and action” on 2 December 2020. For more details and to register please enter the event website here